2.6. Meloxicam Suppresses Hippocampal NOX1/NOX4 Pro-Oxidant Signals and Enhances the Antioxidant Nrf2/HO-1 Pathway in Rats Exposed to CRS. Here, NOX4 is linked to congenital rubella syndrome.